Detalles de la búsqueda
1.
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
N Engl J Med
; 384(1): 20-30, 2021 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33332779
2.
A Review of the Evolving Landscape of Inclusive Research and Improved Clinical Trial Access.
Clin Pharmacol Ther
; 113(3): 518-527, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36536992
3.
Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials-Is Africa the Answer? Report From a Satellite Session of the Accelerating Anti-Cancer Agent Development and Validation Workshop.
JCO Glob Oncol
; 8: e2200117, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35714309
4.
Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials.
Ethn Dis
; 32(1): 61-68, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35106045
5.
JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability.
J Pharmacol Exp Ther
; 338(1): 328-36, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21493750
6.
Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonists.
Bioorg Med Chem Lett
; 20(23): 7137-41, 2010 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20947352
7.
1,2-diamino-ethane-substituted-6,7,8,9-tetrahydro-5H-pyrimido[4,5-d]azepines as TRPV1 antagonists with improved properties.
Bioorg Med Chem Lett
; 20(23): 7142-6, 2010 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20932750
8.
Discovery of potent cholecystokinin-2 receptor antagonists: elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysis.
Bioorg Med Chem
; 16(7): 3917-25, 2008 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18289861
9.
Identification and optimization of anthranilic sulfonamides as novel, selective cholecystokinin-2 receptor antagonists.
J Med Chem
; 49(21): 6371-90, 2006 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-17034143
10.
A novel, quantitative bio-assay for cholecystokinin type-1 receptor activity in the anaesthetised rat.
J Pharmacol Toxicol Methods
; 54(1): 36-41, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16246596
11.
Using patient-initiated study participation in the development of evidence for personalized cancer therapy.
Clin Cancer Res
; 17(21): 6651-7, 2011 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22046027
12.
Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4-d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonist.
Eur J Pharmacol
; 663(1-3): 40-50, 2011 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21575625
13.
3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumide.
J Pharmacol Exp Ther
; 323(2): 562-9, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17684117
Resultados
1 -
13
de 13
1
Próxima >
>>